Clinical challenges in hypertension : therapeutic applications of new vasodliaging B-blockers, Montreal Canada, June 1990BIRKENHÄGER, Willem H; HAMET, Pavel.Journal of cardiovascular pharmacology. 1991, Vol 18, issn 0160-2446, 87 p., SUP4Conference Proceedings

Hypertension and coronary artery disease : a therapeutic challengeTAYLOR, S. H.Journal of cardiovascular pharmacology. 1991, Vol 18, pp S39-S44, issn 0160-2446, SUP4Conference Paper

Design of the Syst-Eur trial and Syst-Eur phase 2: Thomas Weihrauch's contributionsBIRKENHÄGER, Willem H; STAESSEN, Jan A; ZANCHETTI, Alberto et al.Journal of hypertension. 2004, Vol 22, Num 8, pp 1631-1632, issn 0263-6352, 2 p.Article

Essential hypertension : hemodynamic and therapeutic changes over 20 yearsLUND-JOHANSEN, P.Journal of cardiovascular pharmacology. 1991, Vol 18, pp S1-S7, issn 0160-2446, SUP4Conference Paper

Congestive heart failure : pathophysilogy and management with special reference to systemic hypertensionVISSER, F. C.Journal of cardiovascular pharmacology. 1991, Vol 18, pp S8-S11, issn 0160-2446, SUP4Conference Paper

The effects of calcium channel blockers on cardiovascular outcomes: A review of randomised controlled trialsDE LEEUW, Peter W; BIRKENHÄGER, Willem H.Blood pressure. 2002, Vol 11, Num 2, pp 71-78, issn 0803-7051Article

The older hypertensiveBIRKENHÄGER, Willem H; DE LEEUW, Peter W.Blood pressure. 2001, Vol 10, Num 5-6, pp 299-310, issn 0803-7051Article

The interplay of ischemic and hypertensive pathophysiology on cardiac functionFRISHMAN, W. H.Journal of cardiovascular pharmacology. 1991, Vol 18, pp S17-S21, issn 0160-2446, SUP4Conference Paper

The elderly hypertensive; cardiovascular and neurohormonal profile : Hypertension in the elderlyDE LEEUW, Peter W; BIRKENHÄGER, Willem H.Cardiovascular drugs and therapy. 2001, Vol 15, Num 3, pp 263-267, issn 0920-3206Article

Aerteriosclerosis obliterans of the lower limbs as a model of peripheral vascular disease with hypertensionSAFAR, M. E.Journal of cardiovascular pharmacology. 1991, Vol 18, pp S73-S77, issn 0160-2446, SUP4Conference Paper

Less atherosclerosis and lower blood pressure for a meaningful life perspective with more brainSTAESSEN, Jan A; RICHART, Tom; BIRKENHÄGER, Willem H et al.Hypertension (Dallas, Tex. 1979). 2007, Vol 49, Num 3, pp 389-400, issn 0194-911X, 12 p.Article

Outcome beyond blood pressure control?STAESSEN, Jan A; WANG, Ji-Guang; BIRKENHÄGER, Willem H et al.European heart journal. 2003, Vol 24, Num 6, pp 504-514, issn 0195-668X, 11 p.Article

Antihypertensive treatment in concomitant peripheral vascular disease : current experience and the potential of carvedilolBRECKENRIDGE, A; ROBERTS, D. H.Journal of cardiovascular pharmacology. 1991, Vol 18, pp S78-S81, issn 0160-2446, SUP4Conference Paper

Essential hypertensionSTAESSEN, Jan A; JIGUANG WANG; BIANCHI, Giuseppe et al.Lancet (British edition). 2003, Vol 361, Num 9369, pp 1629-1641, issn 0140-6736, 13 p.Article

A multicenter comparison of carvedilol with hydrochlorothiazide in the treatment of mild-to-moderate essential hypertensionLANGDON, C. G; BAXTER, G. A; YOUNG, P. H et al.Journal of cardiovascular pharmacology. 1991, Vol 18, pp S51-S56, issn 0160-2446, SUP4Conference Paper

Features of the acute hypotensive action of carvedilol and its ameliorating effect on myocardial ischemiaHASHIMOTO, H; KANDA, A; HUBO, H et al.Journal of cardiovascular pharmacology. 1991, Vol 18, pp S22-S28, issn 0160-2446, SUP4Conference Paper

The kidney in hypertension treatment strategiesHOLLENBERG, N. K; RODICIO, J. L.Journal of cardiovascular pharmacology. 1991, Vol 18, pp S57-S61, issn 0160-2446, SUP4Conference Paper

Blood pressure, cognitive functions, and prevention of dementias in older patients with hypertensionBIRKENHÄGER, Willem H; FORETTE, Francoise; SEUX, Marie-Laure et al.Archives of internal medicine (1960). 2001, Vol 161, Num 2, pp 152-156, issn 0003-9926Article

Pharmacokinetics and efficacy of cavedilol in chronic hemodialysis patients with hypertensionMIKI, S; MASUMURA, H; KAIFU, Y et al.Journal of cardiovascular pharmacology. 1991, Vol 18, pp S62-S68, issn 0160-2446, SUP4Conference Paper

Comparison of the effects of carvedilol, propanolol, and verapamil on in vitro platelet function in healthy volunteersGASSER, J. A; BETTERRIDGE, D. J.Journal of cardiovascular pharmacology. 1991, Vol 18, pp S29-S34, issn 0160-2446, SUP4Conference Paper

The effects of intravenous carvedilol, a new multiple action vasodilatory β-blocker, in congestive heart failureDASGUPTA, P; BROADHURST, P; LAHIRI, A et al.Journal of cardiovascular pharmacology. 1991, Vol 18, pp S12-S16, issn 0160-2446, SUP4Conference Paper

Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension : a randomised, double-blind trialBIRKENHÄGER, Willem H; STAESSEN, Jan A; OPARIL, Suzanne et al.Lancet (British edition). 2007, Vol 370, Num 9583, issn 0140-6736, 195-196, 221-229 [11 p.]Article

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm ASCOT-BPLA : a multicentre randomised controlled trial. CommentaryDAHLÖF, Bjorn; SEVER, Peter S; MEHLSEN, Jesper et al.SEVER, Peter S; Lancet (British edition). 2005, Vol 366, Num 9489, pp 869-871, issn 0140-6736, 22 p.Article

A comparative study of carvedilol, slow-release nifedipine, and atenolol in the management of essential hypertensionHALL, S; PRESCOTT, R. I; HALLMAN, R. J et al.Journal of cardiovascular pharmacology. 1991, Vol 18, pp S35-S38, issn 0160-2446, SUP4Conference Paper

Effects of carvedilol on serum lipids in patients with essential hypertensionGOTO, Y; TAMACHI, H; FUSEGAWA, Y et al.Journal of cardiovascular pharmacology. 1991, Vol 18, pp S45-S50, issn 0160-2446, SUP4Conference Paper